Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Pain, Postoperative 2Neurotoxicity Syndromes 2Neoplasms 2Colonic Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Immunodeficiency Diseases 1Paclitaxel-induced Neuropathy 1Myoma 1Mesothelioma 1Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Brain Neoplasms 1Anesthesia 1

Interventions

Rituximab 4Valganciclovir 2Valacyclovir 2Carboplatin 2Acyclovir 2valomaciclovir 1threonic acid 1otelixizumab 1cc-486 1Zidovudine 1Vincristine 1Vaccines 1Tomography, X-Ray Computed 1Prednisone 1Polymerase Chain Reaction 1Methotrexate 1Matrix-M 1Magnesium Sulfate 1MVA vaccine 1Leucovorin 1Kidney Transplantation 1Interferons 1In Situ Hybridization 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Gene-Eden-VIR 1Gastrectomy 1Flow Cytometry 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Epstein-Barr Virus Infections × Magnesium Sulfate × Clear all
NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡